Published on
September 20, 2016
- 18:25 GMT
LATITUDE Pharmaceuticals Receives USPTO Notice of Allowance for Novel Injectable Depot Formulation Platform
Phospholipid Gel Depot SAN DIEGO , CA, U.S.A., September 20, 2016 /EINPresswire.com/ -- San Diego-based drug formulation specialist LATITUDE Pharmaceuticals, Inc. (LATITUDE), announced today that it has received a notice of allowance from the United …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Science
...
